About the Breast Oncology Session
Breast oncology encompasses the prevention, diagnosis, molecular characterization, and multidisciplinary treatment of breast cancer across different stages and biological subtypes. This session highlights advances in early and metastatic disease, biomarker-driven treatment, systemic therapies, immunotherapy, surgery, radiation, and long-term management.
Abstract Scope and Participation
Abstracts are welcomed on breast cancer biology, screening, diagnosis, hormone receptor-positive disease, HER2-positive disease, triple-negative breast cancer, metastatic disease, systemic treatment, surgery, radiation, immunotherapy, and survivorship. Clinicians, researchers, surgeons, radiologists, pathologists, and allied specialists are encouraged to contribute.
Topics Covered in Breast Oncology
Topic 01
Breast Cancer Biology
Topic 02
Early Breast Cancer
Topic 03
Metastatic Breast Cancer
Topic 04
HER2-Positive Cancer
Topic 05
Triple-Negative Cancer
Topic 06
Breast Cancer Survivorship
Featured Speakers — Breast Oncology 2027
Recent Research Presented at Breast Oncology Sessions
Evolving concepts of breast cancer management and recent trends
The prognosis of breast cancer remains unpredictable despite of frequent change in treatment protocol since last few decades. As we understand the heterogenous nature of the disease, complex tumor…
tRNA-derived fragment 3'tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Background Drug resistance, including Adriamycin-based therapeutic resistance, remains a challenge in breast cancer (BC) treatment. Studies have revealed that macrophages could play a pivotal role in…
Development of risk stratification tool to appropriately triage the patients at risk of recurrence in HR+ HER2- early breast cancer
Introduction: HR+/HER2-negative Early Breast Cancer (EBC) is treated with curative intent, but managing locoregional and distant recurrences remains a significant challenge. The lack of a standard…
Related Scientific Sessions at CIOC 2027
Why Attend the Breast Oncology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Breast Oncology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Breast Oncology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Breast Oncology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Breast Oncology Conference 2027 — FAQs
What is the Breast Oncology track at CIOC 2027?
The Breast Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Breast Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Breast Oncology sessions?
Cancer researchers and clinicians, educators and students with an interest in Breast Oncology are all welcome — whether presenting or attending.
Can I present my research in the Breast Oncology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Breast Oncology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Breast Oncology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.